A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Fixed-Dose Study Evaluating the Safety and Tolerability of a Single Administration of MDX (Metadoxine Extended Release) in Adolescents With Predominantly Inattentive ADHD

New Research Poster Presentation 6.20
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Fixed-Dose Study Evaluating the Safety and Tolerability of a Single Administration of MDX (Metadoxine Extended Release) in Adolescents With Predominantly Inattentive ADHD

Saturday, October 31, 2015 10:00 AM

Iris Manor, MD, ADHD Unit, Geha MHC, Petach-Tiqva, Israel

Eran Harary, MD, Alcobra Pharma, Tel Aviv, Israel

Jonathan Rubin, MD, MBA, Alcobra Pharma, Philadelphia, PA

Yaron Daniely, MBA, PhD, Alcobra Pharma, Tel Aviv, Israel